SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!
Jonathan
Lv5
3
1580 积分
2024-06-08 加入
最近求助
最近应助
互助留言
Exercise effects on maternal vascular health and blood pressure during pregnancy and postpartum: a systematic review and meta-analysis
1天前
待确认
Comparative effectiveness of prophylactic strategies for preeclampsia: a network meta-analysis of randomized controlled trials
1天前
已完结
Comparative efficacy and tolerability of first-line treatments for untreated, HER2-negative, advanced gastric cancer: systematic review and network meta-analysis
6天前
已完结
Unveiling adipose populations linked to metabolic health in obesity
7天前
已完结
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
8天前
已完结
Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial
8天前
已完结
Multi-Center Phase II Study of Nab-Paclitaxel Plus Camrelizumab Versus Nab-Paclitaxel Alone as Second-Line Treatment for Advanced Gastric Cancer
8天前
已完结
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
8天前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
8天前
已完结
Efficacy of ramucirumab combination chemotherapy as second‐line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to checkpoint inhibitors and chemotherapy as first‐line therapy
8天前
已完结
没有进行任何应助
不需要了【积分已退回】
25天前
不需要了【积分已退回】
25天前
所下文献非要求文献
25天前
不需要了【积分已退回】
1个月前
不需要了【积分已退回】
1个月前
不需要了【积分已退回】
1个月前
不需要了【积分已退回】
1个月前
不需要了【积分已退回】
3个月前
不需要了【积分已退回】
4个月前
感谢
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论